Miami, April 6, 2022 – Privately-held company Guard Medical Inc. today announces the completion of a Series B investment of $11 million to support commercialization and clinical studies of its next generation Negative Pressure Wound Therapy (NPWT) dressing NPseal™ for the treatment of closed surgical incisions. NPseal™ is an easy-to-use and cost-effective NPWT surgical dressing with an integrated pump that establishes and maintains negative pressure with just a few pinches. “The completion of the Series B demonstrates the confidence of the investors to support the next phase of our NPseal™. Securing additional funding will enable new clinical studies, increased commercialization and leveraging the NPseal™ technology into the high exuding and chronic wounds segments,” stated Machiel van der Leest, CEO of Guard Medical. “The now confirmed NPseal™ ease-of-use and cost effectiveness makes, for the first time, prophylactic use of NPWT for all eligible closed surgical incisions possible.” NPWT has been shown to reduce Surgical Site Infections (SSI) in a large number of peer reviewed articles but is in limited use due to its high cost and complexity. While being easy-to-use, NPseal™ delivers the same NPWT as the more expensive and complex NPWT competitive devices. – end – Guard Medical Inc. (www.guard-medical.com), a privately-held company, is developing easy-to-use and cost-effective solutions that enables prophylactic Negative Pressure Wound Therapy (NPWT) wound care of closed surgical incisions. Guard Medical’s simple NPWT technology originated with NewYork-Presbyterian and Weill Cornell Medicine in response to physician’s identification of unmet needs related to Surgical Site Infections (SSI). Current investors include Bpifrance and Matignon Investissement et Gestion. Guard Medical’s vision is to develop NPWT solutions for use on a wide range of surgical wound types and sizes with broad applications for infection prevention, scar mitigation and enhanced cosmesis. For further information please contact: info@guard-medical.com
Announcement shared from AAHKS: Each year, all industry partners and exhibitors are encouraged to apply for the Industry Innovation Award. This is a competitive product award for companies exhibiting at the AAHKS Annual Meeting. At the 2024 Annual Meeting, we...
Read MoreNew York, June 29, 2020 – Privately-held Guard Medical Inc. today announces a substantial cash infusion of $5 million following the achievement of the important milestone of FDA 510k clearance for its next generation Negative Pressure...
Read MoreMiami, August 19, 2024 – Privately-held company Guard Medical Inc. today announces FDA 510(k) clearance for additional large sizes (surgical wounds up to 25cm) of its next generation Negative Pressure Wound Therapy (NPWT)...
Read More